Mounting discontents of some foreign firms over the insurance price re-assessment

The Ministry of Health and Welfare says that some pioneer drugs of foreign invested firms, which are intended to be re-listed as insurance drugs by switching their local production into importation, will be subjected to a 80 percent pricing level lower than their originally listed insurance prices, when any generics in the same ingredients and/or therapeutic category are already registered in t...